Importantly, this breakthrough allows us to predict if a certain patient is likely to benefit from therapy.
Raleigh, NC (PRWEB) July 21, 2015
Scientists at Flinders Medical Centre say they have successfully used the plant polyphenol curcumin to slow the growth of mesothelioma cells taken from their own patients. To understand how this new research may impact future treatment, click here to read the article Surviving Mesothelioma has just posted.
Curcumin comes from the plant that produces the spice turmeric. Although it has been used to slow the growth of mesothelioma cells taken from animal models, the new research represents the first time the same thing has been done with cells from human mesothelioma patients.
“Importantly, this breakthrough allows us to predict if a certain patient is likely to benefit from therapy,” says researcher and author Sonja Klebe, an Associate Professor in the Department of Anatomical Pathology at Flinders Medical Centre.
News of the research was recently published in the Flinders Medical Centre publication Southern Health News. Dr. Klebe says it may impact how mesothelioma patients are treated.
“If it does prove to be possible to predict which mesothelioma patients can benefit from the addition of curcumin to their treatment regimen, then it may also be possible to reduce the amount of traditional medication they have to take and, in turn, reduce unpleasant side effects,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.
You can read more about the Flinders study and the promise of curcumin on the Surviving Mesothelioma website. See Predicting the Success of Curcumin Treatment for Mesothelioma.
Van Santen, J, “Spicy treatment for aggressive cancer”, Southern Health News, Flinders Medical Center Publication, June 2015, http://southernhealthnews.realviewdigital.com/#folio=2
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.